[News Brief] Everest Medicines Signs Share Purchase Agreement with Hasten Biopharmaceuticals
Everest Medicines has entered a share purchase agreement to acquire Hasten Biopharmaceuticals (SG) Pte. Ltd., aiming to expand its commercial…
Pharmaceuticals & Supplements
[News Brief] UBT251 Phase 2 Trial Shows HbA1c Reduction in Chinese Patients with Type 2 Diabetes
United Biotechnology and Novo Nordisk have reported topline results from a phase 2 trial of UBT251 in Chinese patients with…
[News Brief] Cirrus Therapeutics Expands to Singapore with R&D Site
Cirrus Therapeutics has expanded into Singapore with a new R&D site and formed a partnership with A*STAR to advance ophthalmic…
[News Brief] ImmunoScape Signs MoU for US Cancer Clinical Trial
ImmunoScape has signed a Memorandum of Understanding with a US-based cancer centre to launch an investigator-initiated clinical trial targeting WT1-positive…
[News Brief] Next Generation Sequencing Gains Traction in APAC Biologics
PathoQuest highlighted the growing adoption of next generation sequencing (NGS) in Asia-Pacific biologics development, supporting viral safety, contamination detection, and…
[News Brief] Nelipak Opens Asia-Pacific Packaging Development Centre in Singapore
Nelipak Corporation has opened an Asia-Pacific Technical Development Center in Singapore to integrate flexible and rigid sterile packaging development, supporting…
[News Brief] Maersk Opens Automated Distribution Hub in Singapore
A.P. Moller – Maersk has launched a 1.1 million sq. ft. fully automated distribution centre, World Gateway II, in Singapore…
[News Brief] MGI and NUS Partner on Multi-Omics Lab for Drug Discovery
MGI Tech Singapore and the National University of Singapore’s Department of Pharmacy and Pharmaceutical Sciences have collaborated to establish a…
[News Brief] EDDC Partners Daiichi Sankyo on NK Cell Cancer Therapy
[News Brief] EDDC Partners Daiichi Sankyo on NK Cell Cancer Therapy Singapore’s Experimental Drug Development Centre (EDDC) has entered a…
[News Brief] Lucence, DxD Hub and NCCS Partner for Cancer Diagnostics
Lucence, the Diagnostics Development Hub (DxD Hub), and the National Cancer Centre Singapore (NCCS) have launched UNITED 2.0, a S$6…